Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The innate killer cell (IKC) immunological synapse is a specialized, highly organized supramolecular activation cluster (SMAC) formed at the interface between an innate killer cell—such as a Natural Killer (NK) cell, Natural Killer T (NKT) cell, or γδ T cell—and a target cell, typically a malignant or virus-infected cell [1, 10]. This synapse is characterized by the dynamic rearrangement of the actin cytoskeleton and the clustering of activating receptors (e.g., NKG2D, CD16, NKp46) and adhesion molecules (e.g., LFA-1) at the central and peripheral zones [10]. The formation of a stable synapse is essential for the polarized secretion of lytic granules containing perforin and granzymes, which induce apoptosis in the target cell [1, 10]. In therapeutic contexts, this synapse is the primary target of bispecific killer engagers (BiKEs), trispecific killer engagers (TriKEs), and chimeric antigen receptor (CAR)-engineered IKCs, which are designed to bypass inhibitory signals and force the assembly of a functional lytic interface [1, 9]. Dysregulation or failure to form an effective synapse is a key mechanism of immune evasion in cancer and chronic viral infections [7].
Induction of lytic granule exocytosis and target cell apoptosis through the coordinated clustering of activating receptors and the exclusion of inhibitory signals at the cellular interface.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Innate killer cell immunological synapse (IKC-IS).